Class 3 Recall
Update: Returns for credit must be received by Friday 20th March 2020
Glaxo Wellcome UK Ltd T/A GSK has informed us of an issue related to error in the decommissioning of the below batch. Upon decommissioning at the pharmacy and when scanning the serialised 2D code, the status of packs may report as ‘DESTROYED.' Although there is no risk to product quality, any remaining stock should be quarantined and returned.
Please visit the: MHRA website for more details on this drug alert.
The affected products' details are as follows:
PIP Code | Product Description | Supplier | Affected Batch |
---|---|---|---|
383307 | BECONASE AQ NASAL 50MCG | GLAXOSMITHKLINE UK LTD | K84X |
For stock control enquiries please contact 0800 221441.
For medical information enquiries please contact ukmedinfo@gsk.com , via the Live Chat facility or on 0800 221 441 (option 2).
Recipients of this Drug Alert should bring it to the attention of relevant contacts.
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
If you have any questions, then please contact your local Service Centre Customer Services team.